Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PK

Peter Kufer — 65 Patents

AMAmgen: 61 patents #2 of 2,867Top 1%
MAMicromet Ag: 13 patents #1 of 65Top 2%
BOBOE: 2 patents #5,948 of 12,373Top 50%
UGUniversiteit Gent: 1 patents #290 of 823Top 40%
VVVib Vzw: 1 patents #158 of 333Top 50%
Munich, DE: #40 of 11,432 inventorsTop 1%
Overall (All Time): #33,516 of 4,157,543Top 1%
65 Patents All Time
Peter Kufer has been granted 65 US patents while listed as an inventor at Amgen. The first was granted in 2002 and the most recent in October 2025. Peter Kufer ranks #33,516 of 4,157,543 US inventors in our database (top 0.81%). Patent records list Peter Kufer in Munich, DE.

Issued Patents All Time

Showing 1–25 of 65 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12441796 Antibody constructs for CDH19 and CD3 Shengdong Xiao, Zhiyu Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2025-10-14
12435139 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Ralf Lutterbüse +2 more 2025-10-07
12428491 PSMA and CD3 bispecific T cell engaging antibody constructs Tobias Raum, Markus Münz, Johannes Brozy, Patrick Hoffmann, Matthias Friedrich +4 more 2025-09-30
12304952 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Ralf Lutterbüse +2 more 2025-05-20
12297292 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, Patrick Hoffmann, Tobias Raum +3 more 2025-05-13
12281176 Binding molecules for BCMA and CD3 Tobias Raum, Patrick Hoffmann, Roman Kischel, Ralf Lutterbuese, Doris Rau +4 more 2025-04-22
12281172 Cross-species-specific PSMAxCD3 bispecific single chain antibody Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffmann, Doris Rau +6 more 2025-04-22
12281175 Binding molecules for BCMA and CD3 Tobias Raum, Patrick Hoffmann, Roman Kischel, Ralf Lutterbuese, Doris Rau +4 more 2025-04-22
12152078 Nucleic acids encoding anitbody constructs binding EGFR VIII and CD3 Tobias Raum, Ines Herrmann, Patrick Hoffmann, Markus Muenz, Doris Rau 2024-11-26
11987633 Cross-species-specific single domain bispecific single chain antibody Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffmann, Matthias Klinger +2 more 2024-05-21
11926666 Bispecific antibody constructs for CDH3 and CD3 Bertram Weiss, Anna-Lena Frisk, Ruprecht Zierz, Tobias Raum, Doris Rau +6 more 2024-03-12
11925684 Compositions comprising cross-species-specific antibodies and uses thereof Roman Kischel, Tobias Raum, Bernd Schlereth, Doris Rau, Ronny Cierpka 2024-03-12
11884720 Antibody constructs for MSLN and CD3 Tobias Raum, Jonas Anlahr, Julie Bailis, Claudia Blümel, Patrick Hoffmann +2 more 2024-01-30
11661462 Optimized cross-species specific bispecific single chain antibody contructs Benno Rattel, Matthias Friedrich, Patrick Hoffmann, Tobias Raum, Markus Münz +3 more 2023-05-30
11591396 Antibody constructs for DLL3 and CD3 Tobias Raum, Claudia Blümel, Christoph Dahlhoff, Patrick Hoffmann, Ralf Lutterbüse +2 more 2023-02-28
11498964 Antibody constructs for CDH19 and CD3 Shouhua Xiao, Zheng Pan, Dineli Wickramasinghe, M. Shawn Jeffries, Chadwick Terence King +8 more 2022-11-15 $332,140,000
11472886 Cross-species-specific PSMAxCD3 bispecific single chain antibody Tobias Raum, Roman Kischel, Ralf Lutterbüse, Patrick Hoffmann, Doris Rau +6 more 2022-10-18
11434302 Bispecific T cell engaging antibody constructs Tobias Raum, Markus Münz, Johannes Brozy, Patrick Hoffmann, Matthias Friedrich +4 more 2022-09-06
11352433 BCMA and CD3 bispecific T cell engaging antibody constructs Tobias Raum, Markus Münz, Johannes Brozy, Patrick Hoffmann, Matthias Friedrich +4 more 2022-06-07 $374,391,000
11155629 Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 Tobias Raum, Ines Herrmann, Patrick Hoffmann, Markus Muenz, Doris Rau 2021-10-26
11154617 Means and methods for the treament of B cell non-hodgkin lymphoma and B cell leukemia Patrick Baeuerle, Matthias Klinger, Eugen Leo 2021-10-26
11084876 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains Dirk Nagorsen, Juergen Scheele, Gerhard Zugmaier, Matthias Klinger, Patrick Hoffmann +2 more 2021-08-10
11079381 Risk-stratification of B-precursor acute lymphoblastic leukemia patients Gerhard Zugmaier, Shilpa Alekar 2021-08-03 $105,290,000
11053318 Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia Gerhard Zugmaier, Roman Kischel, Marion Subklewe, Christina Heitmueller 2021-07-06
11028171 Bispecific antibody constructs for CDH3 and CD3 Bertram Weiss, Ann-Lena Frisk, Ruprecht Zierz, Tobias Raum, Doris Rau +6 more 2021-06-08